Who holds ACADACADIA PHARMACEUTICALS
23 funds on our shelf carry ACADIA PHARMACEUTICALS — heaviest hand: IBRN at 3.46% of its book.
| Fund | Weight | Fund assets | Shares held | |
|---|---|---|---|---|
| IBRNiShares Neuroscience and Healthcare ETF | INDEX | 3.46% | $6M | 10,995 |
| PBEInvesco Biotechnology & Genome ETF | ACTIVE | 1.76% | $423M | 382,973 |
| PSCHInvesco S&P SmallCap Health Care ETF | INDEX | 1.34% | $178M | 117,705 |
| RZGInvesco S&P SmallCap 600 Pure Growth ETF | INDEX | 0.97% | $121M | 57,688 |
| XBIState Street SPDR S&P Biotech ETF | INDEX | 0.93% | $10.3B | 3,962,517 |
| IJTiShares S&P Small-Cap 600 Growth ETF | INDEX | 0.40% | $7.7B | 1,174,447 |
| SLYGState Street SPDR S&P 600 Small Cap Growth ETF | INDEX | 0.31% | $4.8B | 735,641 |
| VIOGVanguard S&P Small-Cap 600 Growth ETF | INDEX | 0.31% | $954M | 160,378 |
| AGNGGlobal X Aging Population ETF | INDEX | 0.26% | $64M | 11,703 |
| IBBiShares Biotechnology ETF | INDEX | 0.24% | $10.6B | 1,293,944 |
| XJRiShares ESG Screened S&P Small-Cap ETF | INDEX | 0.23% | $207M | 17,262 |
| IBBQInvesco Nasdaq Biotechnology ETF | INDEX | 0.23% | $112M | 13,221 |
| ESIXSPDR S&P SmallCap 600 ESG ETF | INDEX | 0.22% | — | 806 |
| VTWGVanguard Russell 2000 Growth ETF | INDEX | 0.17% | $1B | 140,459 |
| IWOiShares Russell 2000 Growth ETF | INDEX | 0.17% | $14.4B | 1,207,869 |
| SMMViShares MSCI USA Small-Cap Min Vol Factor ETF | INDEX | 0.17% | $270M | 16,924 |
| GWXSPDR S&P International Small Cap ETF | INDEX | 0.09% | $920M | 75,231 |
| IEUSiShares MSCI Europe Small-Cap ETF | INDEX | 0.05% | $164M | 6,967 |
| PDNInvesco RAFI Developed Markets ex-U.S. Small-Mid ETF | INDEX | 0.04% | $349M | 13,154 |
| VHTVanguard Health Care Index Fund | INDEX | 0.03% | $19B | 353,352 |
| ISCFiShares MSCI Intl Small-Cap Multifactor ETF | INDEX | 0.02% | $662M | 14,056 |
| SCZiShares MSCI EAFE Small-Cap ETF | INDEX | 0.02% | $12.7B | 244,268 |
| SPEUState Street SPDR Portfolio Europe ETF | INDEX | 0.01% | $692M | 3,491 |
LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS